摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲基-N-(2-丙炔基)-2-吡咯烷酮 | 18327-34-9

中文名称
5-甲基-N-(2-丙炔基)-2-吡咯烷酮
中文别名
——
英文名称
5-methyl-N-(2-propynyl)-2-pyrrolidone
英文别名
5-methyl-N-2-propynyl-2-pyrrolidone;5-methyl-1-prop-2-ynyl-pyrrolidin-2-one;1-(2-Propinyl)-5-methyl-2-pyrrolidinon;N-Propargyl-5-methyl-2-pyrrolidon;5-Methyl-1-prop-2-ynylpyrrolidin-2-one
5-甲基-N-(2-丙炔基)-2-吡咯烷酮化学式
CAS
18327-34-9
化学式
C8H11NO
mdl
——
分子量
137.181
InChiKey
AXTFWTYUCLLLEO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    75 °C(Press: 1.0 Torr)
  • 密度:
    1.022±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    5-Methyl-2-pyrrolidone analogs of oxotremorine as selective muscarinic agonists
    摘要:
    A series of N-(4-amino-2-butynyl)-5-methyl-2-pyrrolidones modified only in the amino group was synthesized. The compounds were agonists, partial agonists, and antagonists on the isolated guinea pig ileum. They had greater affinity and lower intrinsic efficacy at ileal muscarinic receptors than the identically modified N-(4-amino-2-butynyl)-2-pyrrolidones and N-(4-amino-2-butynyl)succinimides. Dissociation constants in the three series were correlated, suggesting that the compounds had similar mode of binding to muscarinic receptors. The 5-methyl-2-pyrrolidones were 10- to 20-fold less potent as muscarinic agonists on the guinea pig urinary bladder than on the ileum and also elicited lower relative maximal responses on the bladder. For example, the trimethylammonium (9) and azetidino (10) analogues were equipotent (EC50 = 0.2 microM) with the selective muscarinic stimulant N-(1-methyl-4-pyrrolidino-2-butynyl)-N-methylacetamide, BM 5 (2), as agonists on the ileum, but on the bladder 9 and 10 were relatively weak partial agonists, whereas 2 was an antagonist. Compound 10, like 2 and the dimethylamino analogue 8, also differentiated between centrally mediated muscarinic effects in vivo as it was potent in producing analgesia and hypothermia but did not elicit tremor. Instead, 10 antagonized oxotremorine-induced tremor. Thus, 10 resembled 2 in its actions except that the greater intrinsic efficacy of 10 shifted the balance between agonist and antagonist properties slightly toward agonism. Manipulation of intrinsic efficacy by minor changes in chemical structure is emphasized as a means of attaining selectivity.
    DOI:
    10.1021/jm00398a031
  • 作为产物:
    描述:
    5-甲基-2-吡咯烷酮3-溴丙炔氢氧化钾四丁基溴化铵 作用下, 以 四氢呋喃 为溶剂, 反应 6.0h, 以87%的产率得到5-甲基-N-(2-丙炔基)-2-吡咯烷酮
    参考文献:
    名称:
    .beta.-Lactam analogs of oxotremorine. 3- and 4-Methyl-substituted 2-azetidinones
    摘要:
    Four beta-lactam analogues (8-11) of oxotremorine were synthesized and assayed for muscarinic and antimuscarinic activity on the isolated guinea pig ileum. The pharmacological results were compared with those obtained previously with the beta-lactam analogue 7 and the 3-, 4-, and 5-methyl-substituted 2-pyrrolidones 2-6. The new compounds were less potent than the corresponding 2-pyrrolidones, regardless of whether they showed agonist (10 and 11), partial agonist (8), or antagonist properties (9) in the ileum assay. The agonists 10 and 11 were about 200-fold less potent than 7. Compounds 8-11 also were less potent than the similarly substituted 2-pyrrolidones in inhibiting the binding of the muscarinic antagonist (-)-[3H]-N-methylscopolamine in homogenates of the rat cerebral cortex.
    DOI:
    10.1021/jm00164a018
点击查看最新优质反应信息

文献信息

  • Cholinergic activity of acetylenic imidazoles and related compounds
    作者:Malcolm W. Moon、Connie G. Chidester、Richard F. Heier、Jeanette K. Morris、R. James Collins、Roland R. Russell、Jonathan W. Francis、G. Patrick Sage、Vimala H. Sethy
    DOI:10.1021/jm00112a002
    日期:1991.8
    alpha-position in the acetylenic chain (8b) were antagonists. Various analogues of these imidazole acetylenes where the pyrrolidinone ring was replaced by an amide, carbamate, or urea residue were prepared. Several compounds which contained 5-methylimidazole as the amine substituent were partial agonists. The activities of the imidazole compounds are compared with those of the related pyrrolidine and dimethylamine
    制备了一系列与oxotremorine相关的炔属咪唑(1a),并通过体外结合试验和小鼠体内药理学试验评估了它们为胆碱能药物。1- [4-(1H-咪唑-1-基)-2-丁炔基] -2-吡咯烷酮(1b)是胆碱能激动剂,代雷莫林的效力为二分之一。在咪唑环中具有5-或2-甲基取代基的1b的类似物(化合物1c和1g)是胆碱能部分激动剂。1b在吡咯环的5位(7b)或炔链的α位(8b)具有甲基取代基的类似物是拮抗剂。制备了这些咪唑乙炔的各种类似物,其中吡咯环被酰胺氨基甲酸尿素残基取代。含有5-甲基咪唑作为胺取代基的几种化合物是部分激动剂。将咪唑化合物的活性与相关的吡咯烷和二甲胺类似物的活性进行比较。提出了这些化合物在毒蕈碱受体上的激动剂和拮抗剂构象。
  • Tertiary 3- and 4-haloalkylamine analogs of oxotremorine as prodrugs of potent muscarinic agonists
    作者:Bjorn Ringdahl、Margareth Roch、Donald J. Jenden
    DOI:10.1021/jm00396a024
    日期:1988.1
    A series of tertiary 3- and 4-haloalkylamines related to the muscarinic agent oxotremorine was synthesized. The compounds cyclized in neutral aqueous solution to quaternary ammonium salts, which, in contrast to the parent haloalkylamines, were potent muscarinic agonists in vitro. When administered systemically to mice, the haloalkylamines produced central (tremor and analgesia) and peripheral (salivation)
    合成了一系列与毒蕈碱剂oxotremorine有关的3-和4-卤代烷基叔胺。该化合物在中性溶液中环化成季盐,与母体卤代烷基胺相反,季盐在体外是有效的毒蕈碱激动剂。当全身性给予小鼠时,卤代烷基胺产生中枢(震颤和镇痛)和外周(唾液化)毒蕈碱作用。中央效能取决于环化速率和给药途径。N-甲基-N-(4-丁基)胺衍生物7快速环化(t1 / 2在37°C下不到0.4分钟)并在iv注射但在ip注射时没有震颤,而N-甲基-N-( 3-丙基)胺3缓慢环化(t1 / 2 = 436分钟),并且通过任一给药途径均无震颤。N-甲基-N-(3-丙基)胺4(t1 / 2 = 11分钟)及其代类似物5(t1 / 2 = 14分钟)在诱发静脉内和腹膜内注射毒蕈碱效果方面非常有效。老鼠。结论是,丁胺的卤代烷基胺类似物可以在体内用作强季盐的前药,并且它们能够绕过血盐对这类盐的血脑屏障。
  • Alkylating partial muscarinic agonists related to oxotremorine. N-[4-[(2-Haloethyl)methylamino]-2-butynyl]-5-methyl-2-pyrrolidones
    作者:Bjorn Ringdahl、Margareth Roch、Esther D. Katz、Maria C. Frankland
    DOI:10.1021/jm00123a027
    日期:1989.3
    N-[4-[(2-Chloroethyl)methylamino]-2-butynyl]-5-methyl-2-pyrrolidone (3) and N-[4-[(2-bromoethyl)methylamino]-2-butynyl]-5-methyl-2- pyrrolidone (4) were synthesized. Compounds 3 and 4 cyclized in neutral aqueous solution to an aziridinium ion (4A). The rate constants for the cyclization of 3 and 4 at 37 degrees C were 0.025 and 0.89 min-1, respectively. The aziridinium ion was equipotent with carbachol
    N- [4-[(2-乙基)甲基基] -2-丁炔基] -5-甲基-2-吡咯烷酮(3)和N- [4-[(2-乙基)甲基基] -2-丁炔基] -5合成了-甲基-2-吡咯烷酮(4)。化合物3和4在中性溶液中环化成叠氮鎓离子(4A)。3和4在37摄氏度环化的速率常数分别为0.025和0.89 min-1。在分离的豚鼠回肠上,叠氮鎓离子与卡巴胆碱作为毒蕈碱激动剂是等价的。在使大鼠大脑皮层匀浆中的毒蕈碱受体烷基化方面,它比相应的2-吡咯烷酮生物(2A)更有效。这种较高的效力是由于与2A相比,4A的受体亲和力更大,而不是毒蕈碱受体的烷基化速率常数更大。
  • RINGDAHL, B.;ROCH, M.;KATZ, E. D.;FRANKLAND, M. C., J. MED. CHEM., 32,(1989) N, C. 659-663
    作者:RINGDAHL, B.、ROCH, M.、KATZ, E. D.、FRANKLAND, M. C.
    DOI:——
    日期:——
  • RINGDAHL, BJORN;ROCH, MARGARETH;JENDEN, DONALD J., J. MED. CHEM., 31,(1988) N 1, 160-164
    作者:RINGDAHL, BJORN、ROCH, MARGARETH、JENDEN, DONALD J.
    DOI:——
    日期:——
查看更多

同类化合物

(5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (2R,2''R)-(-)-2,2''-联吡咯烷 麦角甾-7,22-二烯-3-基亚油酸酯 马来酰亚胺霉素 马来酰亚胺基酰肼盐酸盐 马来酰亚胺基甲基-3-马来酰亚胺基丙酸酯 马来酰亚胺丙酰基-dPEG4-NHS 马来酰亚胺-酰胺-PEG6-琥珀酰亚胺酯 马来酰亚胺-酰胺-PEG6-丙酸 马来酰亚胺-酰胺-PEG24-丙酸 马来酰亚胺-酰胺-PEG12-丙酸 马来酰亚胺-四聚乙二醇-羧酸 马来酰亚胺-四聚乙二醇-丙酸叔丁酯 马来酰亚胺-四聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-六聚乙二醇-羧酸 马来酰亚胺-六聚乙二醇-丙酸叔丁酯 马来酰亚胺-八聚乙二醇-丙酸叔丁酯 马来酰亚胺-二聚乙二醇-丙酸叔丁酯 马来酰亚胺-三(乙烯乙二醇)-丙酸 马来酰亚胺-一聚乙二醇-羧酸 马来酰亚胺-一聚乙二醇-丙烯酸琥珀酰亚胺酯 马来酰亚胺-PEG3-羟基 马来酰亚胺-PEG2-胺三氟醋酸盐 马来酰亚胺-PEG2-琥珀酰亚胺酯 马来酰亚胺 频哪醇硼酸酯 顺式草酸双(-3,8-二氮杂双环[4.2.0]辛烷-8-羧酸叔丁酯) 顺式4-甲基吡咯烷酮-3-醇盐酸盐 顺式4-氟吡咯烷酮-3-醇盐酸盐 顺式3,4-二羟基吡咯烷盐酸盐 顺式3,4-二氨基吡咯烷-1-羧酸叔丁酯 顺式-二甲基 1-苄基吡咯烷-3,4-二羧酸 顺式-N-[2-(2,6-二甲基-1-哌啶基)乙基]-2-氧代-4-苯基-1-吡咯烷乙酰胺 顺式-N-Boc-吡咯烷-3,4-二羧酸 顺式-5-苄基-2-叔丁氧羰基六氢吡咯并[3,4-c]吡咯 顺式-5-甲基-1H-六氢吡咯并[3,4-b]吡咯二盐酸盐 顺式-5-氧代六氢环戊二烯并[c]吡咯-2(1H)-羧酸叔丁酯 顺式-5-乙氧羰基-1H-六氢吡咯并[3,4-B]吡咯盐酸盐 顺式-5-(碘甲基)-4-苯基-2-吡咯烷酮 顺式-5-(碘甲基)-4-甲基-2-吡咯烷酮 顺式-4-氧代-六氢-吡咯并[3,4-C]吡咯-2-甲酸叔丁酯 顺式-3-氟-4-羟基吡咯烷-1-羧酸叔丁酯 顺式-3-氟-4-甲基吡咯烷盐酸盐 顺式-2-甲基六氢吡咯并[3,4-c]吡咯 顺式-2,5-二甲基吡咯烷 顺式-1-苄基-3,4-吡咯烷二甲酸二乙酯 顺式-1-甲基六氢吡咯并[3,4-b]吡咯 顺式-(9CI)-3,4-二乙烯-1-(三氟乙酰基)-吡咯烷 顺-八氢环戊[c]吡咯-5-酮盐酸盐 非星匹宁